Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

NMR metabolomics analysis of the effects of 5-lipoxygenase inhibitors on metabolism in glioblastomas.

Morin P Jr, Ferguson D, LeBlanc LM, Hébert MJ, Paré AF, Jean-François J, Surette ME, Touaibia M, Cuperlovic-Culf M.

J Proteome Res. 2013 May 3;12(5):2165-76. doi: 10.1021/pr400026q. Epub 2013 Apr 22.

PMID:
23557402
[PubMed - indexed for MEDLINE]
2.

Caffeic acid phenethyl ester and its amide analogue are potent inhibitors of leukotriene biosynthesis in human polymorphonuclear leukocytes.

Boudreau LH, Maillet J, LeBlanc LM, Jean-François J, Touaibia M, Flamand N, Surette ME.

PLoS One. 2012;7(2):e31833. doi: 10.1371/journal.pone.0031833. Epub 2012 Feb 9.

PMID:
22347509
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

[Lipophilic derivatives of caffeic acid as lipoxygenase inhibitors with antioxidant properties].

Mirzoeva OK, Sud'ina GF, Pushkareva MA, Korshunova GA, Sumbatian NV, Varfolomeev SD.

Bioorg Khim. 1995 Feb;21(2):143-51. Russian.

PMID:
7538294
[PubMed - indexed for MEDLINE]
4.

Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties.

Sud'ina GF, Mirzoeva OK, Pushkareva MA, Korshunova GA, Sumbatyan NV, Varfolomeev SD.

FEBS Lett. 1993 Aug 23;329(1-2):21-4.

PMID:
7689063
[PubMed - indexed for MEDLINE]
Free Article
5.

A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.

Zweifel BS, Hardy MM, Anderson GD, Dufield DR, Pufahl RA, Masferrer JL.

Eur J Pharmacol. 2008 Apr 14;584(1):166-74. doi: 10.1016/j.ejphar.2008.01.021. Epub 2008 Feb 5.

PMID:
18295198
[PubMed - indexed for MEDLINE]
6.

The discovery and development of zileuton: an orally active 5-lipoxygenase inhibitor.

Bell RL, Young PR, Albert D, Lanni C, Summers JB, Brooks DW, Rubin P, Carter GW.

Int J Immunopharmacol. 1992 Apr;14(3):505-10. Review.

PMID:
1618602
[PubMed - indexed for MEDLINE]
7.

Preferential cytotoxicity of caffeic acid phenethyl ester analogues on oral cancer cells.

Lee YJ, Liao PH, Chen WK, Yang CY.

Cancer Lett. 2000 May 29;153(1-2):51-6.

PMID:
10779629
[PubMed - indexed for MEDLINE]
8.

Constituents of Chinese propolis and their antiproliferative activities.

Usia T, Banskota AH, Tezuka Y, Midorikawa K, Matsushige K, Kadota S.

J Nat Prod. 2002 May;65(5):673-6.

PMID:
12027739
[PubMed - indexed for MEDLINE]
9.

Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.

Hong SH, Avis I, Vos MD, Martínez A, Treston AM, Mulshine JL.

Cancer Res. 1999 May 1;59(9):2223-8.

PMID:
10232612
[PubMed - indexed for MEDLINE]
Free Article
10.

Interaction between nitric oxide, reactive oxygen intermediates, and peroxynitrite in the regulation of 5-lipoxygenase metabolism.

Coffey MJ, Phare SM, Peters-Golden M.

Biochim Biophys Acta. 2002 Oct 10;1584(2-3):81-90.

PMID:
12385890
[PubMed - indexed for MEDLINE]
11.

Synthesis of selenium-containing polyphenolic acid esters and evaluation of their effects on antioxidation and 5-lipoxygenase inhibition.

Lin CF, Chang TC, Chiang CC, Tsai HJ, Hsu LY.

Chem Pharm Bull (Tokyo). 2005 Nov;53(11):1402-7.

PMID:
16272721
[PubMed - indexed for MEDLINE]
Free Article
12.

5-Lipoxygenase inhibitors: a review of recent patents (2010-2012).

Hofmann B, Steinhilber D.

Expert Opin Ther Pat. 2013 Jul;23(7):895-909. doi: 10.1517/13543776.2013.791678. Epub 2013 Apr 21. Review.

PMID:
23600432
[PubMed - indexed for MEDLINE]
13.

[5-lipoxygenase inhibitors in asthma therapy].

Tanaka R.

Nihon Rinsho. 1996 Nov;54(11):3040-4. Review. Japanese.

PMID:
8950951
[PubMed - indexed for MEDLINE]
14.

N-Aminoindoline derivatives as inhibitors of 5-lipoxygenase.

Audouin C, Mestdagh N, Lassoie MA, Houssin R, Hénichart JP.

Bioorg Med Chem Lett. 2001 Mar 26;11(6):845-8.

PMID:
11277534
[PubMed - indexed for MEDLINE]
15.

Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin.

Schaible AM, Traber H, Temml V, Noha SM, Filosa R, Peduto A, Weinigel C, Barz D, Schuster D, Werz O.

Biochem Pharmacol. 2013 Aug 15;86(4):476-86. doi: 10.1016/j.bcp.2013.04.015. Epub 2013 Apr 24.

PMID:
23623753
[PubMed - indexed for MEDLINE]
16.

Synthesis and biological evaluation of caffeic acid 3,4-dihydroxyphenethyl ester.

Zhang Z, Xiao B, Chen Q, Lian XY.

J Nat Prod. 2010 Feb 26;73(2):252-4. doi: 10.1021/np900519d.

PMID:
20092326
[PubMed - indexed for MEDLINE]
17.

Evaluation of 5-lipoxygenase inhibitors, zileuton, A-78773 and ICI-D-2138 in an ionophore (A-23187)-induced pleural inflammation model in the rat.

Rao TS, Currie JL, Shaffer AF, Isakson PC.

Life Sci. 1993;53(9):PL147-52.

PMID:
8394967
[PubMed - indexed for MEDLINE]
18.

Designing therapeutically effective 5-lipoxygenase inhibitors.

McMillan RM, Walker ER.

Trends Pharmacol Sci. 1992 Aug;13(8):323-30. Review.

PMID:
1413091
[PubMed - indexed for MEDLINE]
19.

Effects of zileuton and montelukast in mouse experimental spinal cord injury.

Genovese T, Rossi A, Mazzon E, Di Paola R, Muià C, Caminiti R, Bramanti P, Sautebin L, Cuzzocrea S.

Br J Pharmacol. 2008 Feb;153(3):568-82. Epub 2007 Dec 3.

PMID:
18059327
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Oxygen-glucose deprivation activates 5-lipoxygenase mediated by oxidative stress through the p38 mitogen-activated protein kinase pathway in PC12 cells.

Li CT, Zhang WP, Lu YB, Fang SH, Yuan YM, Qi LL, Zhang LH, Huang XJ, Zhang L, Chen Z, Wei EQ.

J Neurosci Res. 2009 Mar;87(4):991-1001. doi: 10.1002/jnr.21913.

PMID:
18951527
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk